Product Description
Industry Trends
There has been increased product innovation throughout the wound and tissue management market in both the European and the U.S. market. Companies are attempting to create products that are easier for physicians to use, fight infection, and take less time for wound closure. Although these products can be more expensive, a smaller quantity is needed during treatment, lowering costs for both patients and hospitals. Recent innovations in the U.S. wound closure market include Zipline Medical’s zip surgical skin closure system and Ethicon’s Dermabond Prineo mesh and cyanoacrylate-based skin closure system.
In the European wound care market, recent innovation in the negative pressure wound therapy market (NPWT) includes the release of single-use pumps. These NPWT pumps are witnessing a higher growth rate and are driving the NPWT market. These markets are growing significantly and driving the overall wound and tissue management market.
Globally, the wound care market is expected to be driven by an aging population as well as rising rates of diabetes, obesity and heart disease. In the Chinese market, these chronic health problems lead to major surgeries, chronic ulcers and other problems, which drive both the wound management and wound closure segments of the market. Further, expanding reimbursement coverage coupled with higher government spending on health care will also stimulate greater demand for wound care products.
Report Regional Coverage
Throughout this research series, iData has covered several countries in great detail. Each country may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are:
- United States
- Europe (15 countries including: Germany, France, U.K., Italy, Spain, Benelux (Belgium, Netherlands and Luxembourg), Scandinavia (Denmark, Finland, Norway and Sweden) Austria, Switzerland and Portugal)
- Japan
- India
- China
- Brazil
- Asia-Pacific
The Only Medical Device Market Research With: |
||||
|---|---|---|---|---|
| ✔ Unit Sales Growth Analysis ✔ Average Selling Prices ✔ Competitor Shares by Segment & Country ✔ SKU-Level Research Methods ✔ The Lowest Acquisition Cost |
 |
|||
Highly Detailed Segmentation
While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:
- Wound Closure Market – MedCore
- Traditional Wound Dressings Market – MedCore
- Advanced Dressings Market– MedCore
- Moist Dressings Market– MedCore
- Antimicrobial Dressings Market– MedCore
- Interactive Dressings Market– MedCore
- Non-Adherent Contact Layers Market – MedCore
- Surgical Hemostats Market– MedCore
- Tissue Sealants Market – MedCore
- Anti-Adhesion Market – MedCore
- Negative Pressure Wound Therapy Market – MedCore
- Static Compression Therapy Market – MedCore
- Dynamic Compression Therapy Market – MedCore
Buying all of these reports together in this suite package will provide you with substantial discounts from the separate prices. Request Pricing to Learn More.
Full Segmentation Map for the United States
Data Types Included
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2025, and Historical Data to 2015
- Market Drivers & Limiters for Each Wound and Tissue Management Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
- Related Press Releases from Top Competitors
Wound Care Market Share Insights
Of the many companies in the U.S. and Europe wound care market, Ethicon is the leading competitor. Ethicon dominates a large number of market segments; its vast product portfolio allows them to bundle a wide range of products and servicing agreements to secure hospital contracts and deter competitors from entering the market.They dominated the wound closure market, making up almost half of the market. They were the market leaders in sutures and skin adhesive segments and also held a significant share of the surgical stapler market.
In the U.S. wound care market, the second leading player in the wound and tissue management market is Acelity. Acelity also held a moderate share of the advanced dressing market, where they competed in the antimicrobial dressing, interactive dressing and non-adherent contact layer market segments.
In the European market, The second-leading competitor in the wound and tissue management market in 2018 was Medtronic, who acquired Covidien in 2015. Medtronic had the second-highest share in the wound closure segment, where they competed in the suture, stapler, ligating clip appliers and tissue adhesive segments. They were the market leader in the stapler segment. Medtronic’s strong growth in the stapler market was primarily driven by increasing demand for their premium Endo-GIA® staplers with Tri-Staple® technology. Medtronic also has a small share in surgical hemostat market, with their Veriset® patch, which is a combination hemostat-containing oxidized regenerated cellulose (ORC) and polyethylene glycol (PEG).
Other significant players in the global market include Smith & Nephew, 3M, ConvaTec, Coloplast, B. Braun, Takeda, and others.
All Companies Analyzed in this Study |
||||
|---|---|---|---|---|
|
|
|||
Statistics Trends
Vascular malformations occur in 1.5% of the general population worldwide, with slight variations indifferent geographic regions. VMs are the most common type of vascular malformations, comprising two-thirds of the condition, with a prevalence of 1% in the general population. Low-flow malformations occur most often in the extremities (40%), followed by the head and neck (40%) and the trunk (20%).10% of the malformations found in the extremities are made up of high-flow malformations. According to the American Association of Neurological Surgeons, AVMs have a prevalence rate of 0.018%, with two-thirds of this proportion occuring before the age of 40. It is estimated that 4% of individuals with AVMs will experience a hemorrhage, and 1% will develop epileptic seizures.
The CDC estimates 214,000 people die from traumatic injury each year. In 2015, 27.6 million people were treated in an emergency department and 2.8 million people were hospitalized due to traumarelated injuries. However, the National Institute of Health (NIH) states that the annual number of traumatic injuries has declined by nearly 5 million between the years 1985 and 2008.
Latest Market Developments
January 1, 2019 – CMS plans to review the competitive bidding process (CBP), and current fees are to remain constant for 2019.
May 2, 2018 – Hollister sell their Hydrofera Blue® and Endoform® products back to the founders, Hydrofera LLC and Aroa Biosurgery, who team up to create Appulse.
January 8, 2018 – Baxter acquires Recothrom® and Preveleak® products fromMallinckrodt.
See many more by requesting a free sample report of this analysis.
